Literature DB >> 35333343

Association of Genetic Ancestry With Terminal Duct Lobular Unit Involution Among Healthy Women.

Hyuna Sung1, Hela Koka2, Natascia Marino3,4, Ruth M Pfeiffer2, Renata Cora2, Jonine D Figueroa5, Mark E Sherman6, Gretchen L Gierach2, Xiaohong R Yang2.   

Abstract

Reduced age-related terminal duct lobular unit (TDLU) involution has been linked to increased breast cancer risk and triple-negative breast cancer. Associations of TDLU involution levels with race and ethnicity remain incompletely explored. Herein, we examined the association between genetic ancestry and TDLU involution in normal breast tissue donated by 2014 healthy women in the United States. Women of African ancestry were more likely than European women to have increased TDLU counts (odds ratio [OR]trend = 1.36, 95% confidence interval [CI] = 1.07 to 1.74), acini counts per TDLU (OR = 1.47, 95% CI = 1.06 to 2.03), and median TDLU span (ORtrend = 1.44, 95% CI = 1.08 to 1.91), indicating lower involution, whereas East Asian descendants were associated with decreased TDLU counts (ORtrend = 0.52, 95% CI = 0.35 to 0.78) after controlling for potential confounders. These associations are consistent with the racial variations in incidence rates of triple-negative breast cancer in the United States and suggest opportunities for future work examining whether TDLU involution may mediate the racial differences in subtype-specific breast cancer risk. Published by Oxford University Press 2022. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Mesh:

Year:  2022        PMID: 35333343      PMCID: PMC9552305          DOI: 10.1093/jnci/djac063

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   11.816


  24 in total

1.  Age-related lobular involution and risk of breast cancer.

Authors:  Tia R Milanese; Lynn C Hartmann; Thomas A Sellers; Marlene H Frost; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; Amy C Degnim; Celine M Vachon; Carol A Reynolds; Romayne A Thompson; L Joseph Melton; Ellen L Goode; Daniel W Visscher
Journal:  J Natl Cancer Inst       Date:  2006-11-15       Impact factor: 13.506

2.  Association between mammographic density and age-related lobular involution of the breast.

Authors:  Karthik Ghosh; Lynn C Hartmann; Carol Reynolds; Daniel W Visscher; Kathleen R Brandt; Robert A Vierkant; Christopher G Scott; Derek C Radisky; Thomas A Sellers; V Shane Pankratz; Celine M Vachon
Journal:  J Clin Oncol       Date:  2010-03-29       Impact factor: 44.544

3.  Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.

Authors:  Jonine D Figueroa; Ruth M Pfeiffer; Louise A Brinton; Maya M Palakal; Amy C Degnim; Derek Radisky; Lynn C Hartmann; Marlene H Frost; Melody L Stallings Mann; Daphne Papathomas; Gretchen L Gierach; Stephen M Hewitt; Maire A Duggan; Daniel Visscher; Mark E Sherman
Journal:  Breast Cancer Res Treat       Date:  2016-08-03       Impact factor: 4.872

4.  The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the "molecular histology" of the breast.

Authors:  Mark E Sherman; Jonine D Figueroa; Jill E Henry; Susan E Clare; Connie Rufenbarger; Anna Maria Storniolo
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-17

5.  Circulating sex hormones and terminal duct lobular unit involution of the normal breast.

Authors:  Zeina G Khodr; Mark E Sherman; Ruth M Pfeiffer; Gretchen L Gierach; Louise A Brinton; Roni T Falk; Deesha A Patel; Laura M Linville; Daphne Papathomas; Susan E Clare; Daniel W Visscher; Carolyn Mies; Stephen M Hewitt; Anna Maria V Storniolo; Adrian Rosebrock; Jesus J Caban; Jonine D Figueroa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12       Impact factor: 4.254

6.  A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium.

Authors:  Julie R Palmer; Christine B Ambrosone; Andrew F Olshan
Journal:  Cancer Causes Control       Date:  2013-12-17       Impact factor: 2.506

7.  Association between mammographic breast density and histologic features of benign breast disease.

Authors:  Karthik Ghosh; Robert A Vierkant; Ryan D Frank; Stacey Winham; Daniel W Visscher; Vernon S Pankratz; Christopher G Scott; Kathleen Brandt; Mark E Sherman; Derek C Radisky; Marlene H Frost; Lynn C Hartmann; Amy C Degnim; Celine M Vachon
Journal:  Breast Cancer Res       Date:  2017-12-19       Impact factor: 6.466

8.  Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors.

Authors:  Changyuan Guo; Hyuna Sung; Shan Zheng; Jennifer Guida; Erni Li; Jing Li; Nan Hu; Joseph Deng; Jonine D Figueroa; Mark E Sherman; Gretchen L Gierach; Ning Lu; Xiaohong R Yang
Journal:  Breast Cancer Res       Date:  2017-05-25       Impact factor: 6.466

9.  Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients.

Authors:  Maeve Mullooly; Sarah J Nyante; Ruth M Pfeiffer; Renata Cora; Donna Butcher; Lawrence Sternberg; Erin J Aiello Bowles; Shaoqi Fan; Jonine D Figueroa; Sheila Weinmann; Robert N Hoover; Louise A Brinton; Amy Berrington de Gonzalez; Andrew Glass; Mark E Sherman; Gretchen L Gierach
Journal:  J Clin Med       Date:  2019-11-04       Impact factor: 4.241

10.  Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast.

Authors:  Gretchen L Gierach; Jonine D Figueroa; Clara Bodelon; Hannah Oh; Andriy Derkach; Joshua N Sampson; Brian L Sprague; Pamela Vacek; Donald L Weaver; Shaoqi Fan; Maya Palakal; Daphne Papathomas; Jackie Xiang; Deesha A Patel; Laura Linville; Susan E Clare; Daniel W Visscher; Carolyn Mies; Stephen M Hewitt; Louise A Brinton; Anna Maria V Storniolo; Chunyan He; Stephen J Chanock; Montserrat Garcia-Closas
Journal:  NPJ Breast Cancer       Date:  2020-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.